Targeted vascular delivery of antisense molecules using intravenous microbubbles

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Thomas R PorterNicholas Kipshidze

Abstract

Perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles bind the antisense to the c-myc protooncogene (anti-c-myc) which prevents neointimal hyperplasia following vascular endothelial injury. The microbubbles also adhere to sites of damaged vascular endothelium and thus may be a method of systemically targeting delivery of anti-c-myc. Laser scanning microscopy was performed on the aorta of 10 mice (five which were complement depleted) that received intravenous FITC-PESDA following aortic endothelial injury. C-myc expression was quantified following selective intracoronary injury in nine pigs that received intravenous (IV) anti-c-myc bound to PESDA. Finally, neointimal formation was measured following intracoronary stent deployment in 30 pigs that received either IV anti-c-myc alone or the same dose bound to PESDA. Fluorescent microscopy confirmed selective PESDA microbubble adherence to aortic endothelium in all mice with aortic injury. This binding was nearly abolished when serum complement was depleted prior to injury. C-myc expression at the site of coronary endothelial injury was significantly lower in pigs treated with systemic anti-c-myc bound to PESDA. There was a 33% reduction in % stenosis and a 28% red...Continue Reading

References

Apr 24, 2001·Ultrasound in Medicine & Biology·T R PorterS Radio
Nov 1, 2001·Journal of the American Chemical Society·B I Kankia, L A Marky
Apr 3, 2002·Echocardiography·Wilson MathiasThomas R Porter
May 22, 2002·Journal of the American College of Cardiology·Nicholas N KipshidzeJeffrey W Moses
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators

❮ Previous
Next ❯

Citations

Feb 4, 2014·Advanced Drug Delivery Reviews·Joshua J Rychak, Alexander L Klibanov
May 14, 2008·Advanced Drug Delivery Reviews·Christian R Mayer, Raffi Bekeredjian
Dec 16, 2006·Progress in Cardiovascular Nursing·Robin J Trupp
Jul 11, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yiyao LiuMichihiro Nakamura
Feb 18, 2010·JACC. Cardiovascular Imaging·Sanjiv Kaul
Jul 29, 2011·Anesthesiology·Marie-Christine Ross-HuotTerence J Coderre
Jan 26, 2010·Nature Reviews. Endocrinology·Abishek IyerLindsay Brown
Sep 18, 2007·Critical Care Nursing Quarterly·Anne Daleiden-Burns, Penelope Stiles
Sep 17, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Nicholas KipshidzeJawed Fareed
Oct 1, 2013·Expert Review of Cardiovascular Therapy·Peter S PangSanjiv J Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.